Multivessel coronary disease | 89 (79%) | 81% |
LMS disease >50% | 17 (15%) | 14% |
Single vessel disease | 24 (21%) | 19% |
Culprit vessel | | |
LAD | 58 (51%) | 50% |
RCA | 33 (29%) | 33% |
Circumflex | 12 (11%) | 9% |
LMS | 6 (5.3%) | 5% |
Unknown | 1 (0.9%) | NA |
Saphenous vein graft | 3 (2.7%) | 4% |
Total occlusion in culprit vessel | 94 (83%) | TIMI 0 or 1, 62% |
Culprit vessel last remaining vessel | 11 (9.7%) | NA |
Stent(s) | 54 (48%) | 34% |
IABP | 103 (91%) | 89% |
Abciximab | 28 (25%) | Gp IIb/IIIa inhibitor, 32% |
Ventilation | 19 (17%) | 84% |
Pacing wire | 21 (19%) | NA |
Inotropic support | 57 (50%) | 100% |
PCI success | 82 (73%) | 76% |